TPRKB Polyclonal antibody
TPRKB Polyclonal Antibody for WB, ELISA
Host / Isotype
Rabbit / IgG
Reactivity
human, mouse, rat
Applications
WB, IHC, ELISA
Conjugate
Unconjugated
Cat no : 12800-1-AP
Synonyms
Validation Data Gallery
Tested Applications
Positive WB detected in | human heart tissue |
Recommended dilution
Application | Dilution |
---|---|
Western Blot (WB) | WB : 1:500-1:1000 |
It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, Check data in validation data gallery. |
Published Applications
WB | See 1 publications below |
IHC | See 1 publications below |
Product Information
12800-1-AP targets TPRKB in WB, IHC, ELISA applications and shows reactivity with human, mouse, rat samples.
Tested Reactivity | human, mouse, rat |
Cited Reactivity | human |
Host / Isotype | Rabbit / IgG |
Class | Polyclonal |
Type | Antibody |
Immunogen | TPRKB fusion protein Ag3551 相同性解析による交差性が予測される生物種 |
Full Name | TP53RK binding protein |
Calculated molecular weight | 175 aa, 20 kDa |
Observed molecular weight | 20 kDa |
GenBank accession number | BC029492 |
Gene symbol | TPRKB |
Gene ID (NCBI) | 51002 |
RRID | AB_2256289 |
Conjugate | Unconjugated |
Form | Liquid |
Purification Method | Antigen affinity purification |
Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol pH 7.3. |
Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. |
Background Information
TPRKB, also named as CGI 121, belongs to the CGI121/TPRKB family. It interacts with TP53RK/PRPK and is widely expressed in all tissues. This antibody is a rabbit polyclonal antibody raised against full length TPRKB of human origin.
Protocols
Product Specific Protocols | |
---|---|
WB protocol for TPRKB antibody 12800-1-AP | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |
Publications
Species | Application | Title |
---|---|---|
Exp Cell Res METTL5 enhances the mRNA stability of TPRKB through m6A modification to facilitate the aggressive phenotypes of hepatocellular carcinoma cell |